More lessons for the treatment of chronic daily headache.
Pascual
Julio
J
Cacabelos
Purificación
P
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000009:adverse effects*; D000927:Anticonvulsants / Q000627:therapeutic use*; D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004334:Drug Administration Schedule; D004599:Electric Stimulation Therapy / Q000706:statistics & numerical data; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D020773:Headache Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology / Q000517:prevention & control; D000077236:Topiramate; D014635:Valproic Acid / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000927:Anticonvulsants; D009466:Neuromuscular Blocking Agents; D000077236:Topiramate; D005632:Fructose; D014635:Valproic Acid